Evidence map›Paper›PMID 32986379›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.

Ahmad Mehrazin, Hossein Safarpour, Seyedeh Tahmineh Davoudi, Negin Parsamanesh, Farhad Saeedi, Ebrahim Miri-Moghaddam

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ahmad MehrazinClinical Immunology Research Center, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Hossein SafarpourCellular and Molecular Research Center, Birjand University of Medical Sciences (BUMS), Birjand, Iran.
Seyedeh Tahmineh DavoudiDepartment of Biology, University of Sistan and Baluchestan, Zahedan, Iran.
Negin ParsamaneshStudent Research Committee and Dep. of Molecular Medicine, School of Medicine, (BUMS), Birjand, Iran.
Farhad SaeediStudent Research Committee, School of Medicine, (BUMS), Birjand, Iran.
Ebrahim Miri-MoghaddamCardiovascular Diseases Research Center and Department of Molecular Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.ORCID 0000-0001-9435-2450
Birjand University of Medical Sciences · IRUniversity of Sistan and Baluchestan · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid cancer (TC) is the mainly frequent endocrine cancer by different incidence rate in worldwide. However, early prediction of  this cancer is still challenging due to the unclear pathogenicity. In this study with the aid of systems biology approach, performed a holistic study on GSE65144 dataset containing anaplastic thyroid carcinoma tissues. Co-expression network analysis by WGCNA suggested that highly preserved turquoise module with 1,480 genes was significantly correlated to TC. Most of the top 54 hub-genes of this module are functionality correlated to thyroid hormone generation (GO:0006590). Of these 54 hub-genes, FOXE1 has been reported previously to contain mutation asosiated to TC and chosen for experimental validation step. To this end, we conducted a case-control study including 81 TC patients and 165 controls individuals to evaluate the effects of FOXE1 functional polymorphisms (rs1867277) on the development of TC in Sistan and Balouchestan province of Iran. The polymorphisms of FOXE1 gene (rs1867277) assessed by tetra-ARMS PCR technique. Homozygous (GG) and (AA) variant of rs1867277 polymorphism were detected in 26 (32.1%) and 15 (18.5 %) of TC patients, and 66 (40.0%), and 15 (9.1%) in controls, respectively (p-value= 0.03, OR= 2.53). The A allele frequency was 70 (43.2%) in TC patients and 114 (34.5%) in controls (p-value= 0.06, OR= 1.44). Overall, our results suggested that FOXE1 gene could be used as a prognostic marker in TC and also provides information related to FOXE1 functional polymorphisms (rs1867277) in Sistan and Balouchestan province of Iran.<br />.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksPolymorphism, Single NucleotideAdultBiomarkers, TumorCarcinoma, PapillaryCase-Control StudiesFemaleFollow-Up StudiesForkhead Transcription FactorsGenetic Predisposition to DiseaseHumansMaleMiddle AgedPrognosisThyroid NeoplasmsBiomarkers, TumorForkhead Transcription FactorsFOXE1 protein, humanFOXE1Systems biologyThyroid cancerWGCNA

Identifiers

PMID32986379
PMCPMC7779442
OpenAlexW3089654125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.